CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Investor Presentation
Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201530-10-2021
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Investor Presentation
Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter And Six Months Ended September 30, 2021.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2021 ,inter alia, to consider and approve Consideration and Approval of Standalone and Consolidated un-audited Financial Results for the quarter and six months ended September 30, 2021.Caplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015Caplin Point Laboratories Ltd - 524742 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Dinesh R GDesignation :- Company Secretary and Compliance OfficerCAPLIN POINT LABORATORIES LTD. - 524742 - Shareholding for the Period Ended September 30, 2021
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click hereCaplin Point Laboratories Ltd - 524742 - Closure of Trading Window
Intimation - Closure of Trading WindowCaplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015CAPLIN POINT LABORATORIES LTD. - 524742 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Caplin Point Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereCAPLIN POINT LABORATORIES LTD. - 524742 - Voting Results And Scrutinizer''s Report
Pursuant to regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we submit herewith the details regarding the voting results (Annexure - A) of the business transacted at the 30th AGM of the Members of the Company held on Tuesday, September 28, 2021 at 10:00 a.m. We also enclose the consolidated report of the scrutinizer on remote e-voting and e-voting at the AGM (Annexure - B). A copy of the above is also available in the website of the Company. This is for your kind information and records.Caplin Point Laboratories Ltd - 524742 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Disclosure of events pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Brief Proceedings of the Thirtieth Annual General Meeting held on Tuesday, September 28, 2021.